Active Plants, Animals & Ecology Infection & Immunity

Catalyzing a Global Ecosystem for Scale-up of Wolbachia-based Interventions to Prevent Dengue and Aedes-Borne Diseases

In plain English

AI plain-English summary

Dengue-carrying mosquitoes are becoming resistant to insecticides, and climate change is expanding their habitat. This project aims to build the global infrastructure needed to deploy a biological alternative: infecting mosquitoes with *Wolbachia* bacteria, which block the insects from transmitting dengue and other viruses. The problem is that while *Wolbachia*-based interventions have shown impressive results in field trials, no system exists to scale them up to the hundreds of millions of people at risk. The researchers—the Clinton Health Access Initiative and the Innovative Vector Control Consortium—plan to create that system. They will work with governments in at least four countries across Central America, Southeast Asia, and sub-Saharan Africa to incorporate *Wolbachia* into national dengue strategies. They will also map out the supply chain for producing and distributing the bacteria-treated mosquitoes, and develop financing mechanisms to pay for it all. If successful, this work could transform dengue control from a patchwork of pilot projects into a coordinated, government-led global programme. The impact would be felt in the everyday lives of people in tropical and subtropical cities, where dengue outbreaks currently overwhelm hospitals and disrupt communities.

View original technical description
Dengue poses a significant and growing global health threat. Mosquito resistance to insecticides is spreading even as global warming and urbanization expand Aedes habitat, increasing risk of dengue and other Aedes- borne viral diseases. Demonstration that certain strains of Wolbachia can inhibit viral growth in the vector offers a sustainable tool to counteract the increasing risk of these diseases. Implementations by World Mosquito Program and others have produced impressive results, but scaling this innovation to all at risk requires a global ecosystem of government-led programs, donors, and suppliers that does not exist today. CHAI and HFC aim to develop the global ecosystem needed to scale Wolbachia-based solutions to mitigate the growing threat of dengue and other arboviruses by: (1) Incorporating Wolbachia-based tools into evidence-based, government-owned national dengue strategies in 4+ countries while gathering intelligence on demand and budget requirements across Central America, Southeast Asia, and sub-Saharan Africa; (2) Quantifying regional supply requirements and engaging suppliers to ensure necessary supply and technical expertise exists to meet demand; (3) Developing financing mechanisms to fund Wolbachia deployment across diverse settings. Together these interrelated workstreams will catalyze scale-up by simultaneously stimulating demand, financing, and affordable supply to realize the potential of this critical health innovation.

View the original record at the funder ↗

Researchers

Colleen Connell (EPMC Awardee)Justin Cohen (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Transitioning the WMP Wolbachia method for arbovirus control to sustainable scale
Development of Wolbachia as an effective and sustainable approach to reduce dengue transmission.
Optimal deployment of Wolbachia for dengue control
World Mosquito Programme
Accelerating the adoption of novel mosquito control interventions by combining entomological, epidemiological and genetic data using modelling

Original classification

Discretionary Award

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.